These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10467384)

  • 1. Recent developments in the assessment of quality of life in multiple sclerosis (MS).
    Fischer JS; LaRocca NG; Miller DM; Ritvo PG; Andrews H; Paty D
    Mult Scler; 1999 Aug; 5(4):251-9. PubMed ID: 10467384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.
    Marrie RA; Miller DM; Chelune GJ; Cohen JA
    Mult Scler; 2003 Dec; 9(6):621-6. PubMed ID: 14664477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness.
    Shawaryn MA; Schiaffino KM; LaRocca NG; Johnston MV
    Mult Scler; 2002 Aug; 8(4):310-8. PubMed ID: 12166502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study.
    Miller DM; Cohen JA; Kooijmans M; Tsao E; Cutter G; Baier M
    Mult Scler; 2006 Apr; 12(2):180-6. PubMed ID: 16629421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
    Sandi D; Rudisch T; Füvesi J; Fricska-Nagy Z; Huszka H; Biernacki T; Langdon DW; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2015 Nov; 4(6):499-504. PubMed ID: 26590654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants.
    Cioncoloni D; Innocenti I; Bartalini S; Santarnecchi E; Rossi S; Rossi A; Ulivelli M
    J Neurol Sci; 2014 Oct; 345(1-2):213-9. PubMed ID: 25130927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the multiple sclerosis quality of life inventory in older individuals.
    Dilorenzo T; Halper J; Picone MA
    Disabil Rehabil; 2003 Aug; 25(16):891-7. PubMed ID: 12857582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis.
    Fernández-Muñoz JJ; Morón-Verdasco A; Cigarán-Méndez M; Muñoz-Hellín E; Pérez-de-Heredia-Torres M; Fernández-de-las-Peñas C
    Acta Neurol Scand; 2015 Aug; 132(2):118-24. PubMed ID: 25644133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the functional assessment of multiple sclerosis quality of life instrument in a Portuguese language].
    Mendes MF; Balsimelli S; Stangehaus G; Tilbery CP
    Arq Neuropsiquiatr; 2004 Mar; 62(1):108-13. PubMed ID: 15122443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.
    Füvesi J; Bencsik K; Losonczi E; Fricska-Nagy Z; Mátyás K; Mészáros E; Benedek K; Rajda C; Lencsés G; Vécsei L
    J Neurol Sci; 2010 Jun; 293(1-2):59-64. PubMed ID: 20394948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire.
    Bonniaud V; Parratte B; Amarenco G; Jackowski D; Didier JP; Guyatt G
    Arch Phys Med Rehabil; 2004 Aug; 85(8):1317-23. PubMed ID: 15295759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neurological impairment, depression, cognitive function and coping on quality of life of people with multiple sclerosis: A relative importance analysis.
    Fernández-Jiménez E; Arnett PA
    Mult Scler; 2015 Oct; 21(11):1468-72. PubMed ID: 25533298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Arch Neurol; 2004 May; 61(5):679-86. PubMed ID: 15148144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
    Campbell J; Rashid W; Cercignani M; Langdon D
    Postgrad Med J; 2017 Mar; 93(1097):143-147. PubMed ID: 27512050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported executive dysfunction, neuropsychological impairment, and functional outcomes in multiple sclerosis.
    Basso MR; Shields IS; Lowery N; Ghormley C; Combs D; Arnett PA; Johnson J
    J Clin Exp Neuropsychol; 2008 Nov; 30(8):920-30. PubMed ID: 18608679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Searching for more specific dimensions for the measurement of quality of life in multiple sclerosis].
    Rivera-Navarro J; Benito-León J; Morales-González JM
    Rev Neurol; 2001 Apr 16-30; 32(8):705-13. PubMed ID: 11391503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of depression, disability, and family caregiver attitudes to the quality of life of Kuwaiti persons with multiple sclerosis: a controlled study.
    Alshubaili AF; Awadalla AW; Ohaeri JU; Mabrouk AA
    BMC Neurol; 2007 Sep; 7():31. PubMed ID: 17877820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
    J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.